• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中药辅助治疗难治性精神分裂症的疗效:系统评价和荟萃分析。

Effectiveness of Traditional Chinese Medicineas as an Adjunct Therapy for Refractory Schizophrenia: A Systematic Review and Meta Analysis.

机构信息

Department of EEG Source Imaging, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, P. R. China.

Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai, 200433, P. R. China.

出版信息

Sci Rep. 2018 Apr 18;8(1):6230. doi: 10.1038/s41598-018-24547-0.

DOI:10.1038/s41598-018-24547-0
PMID:29670200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5906629/
Abstract

Although recent studies focused on traditional Chinese medicine (TCM) for the treatment of refractory schizophrenia have reported that it may be beneficial, there is still lack of convincing evidence and critical meta-analytic work regarding its effectiveness as an adjunctive therapy. Therefore, we performed a meta-analysis to investigate the effectiveness of TCM in combination with antipsychotics for refractory schizophrenia. Fourteen articles involving 1725 patients published as of December 2016 were included which compared antipsychotic therapies to either TCM alone, or TCM as an adjunctive therapy. TCM was observed to have beneficial effects on aspects of the Positive and Negative Syndrome Scale (PANSS) including total score changes and negative score changes, as well as clinical effects estimated with PANSS or the Brief Psychiatric Rating Scale (BPRS). The changes in extrapyramidal side effects (RSESE) scores from baseline to the end of the treatment period were similar in two groups of related trials. TCM was also reported to mitigate some anti-psychotic related side-effects and overall, TCM adjuvant therapy was generally safe and well tolerated. While, the results indicated the potential utility of TCM as an alternative adjunctive therapeutic for refractory schizophrenia treatment, there remains a need for further high-quality studies.

摘要

虽然最近的研究集中在中药(TCM)治疗难治性精神分裂症上,报告称它可能是有益的,但仍然缺乏令人信服的证据和关键的荟萃分析工作,以证明其作为辅助治疗的有效性。因此,我们进行了一项荟萃分析,以调查 TCM 联合抗精神病药物治疗难治性精神分裂症的疗效。纳入了截至 2016 年 12 月发表的 14 篇文章,共涉及 1725 名患者,这些文章比较了抗精神病药物治疗与 TCM 单独治疗或 TCM 作为辅助治疗的效果。结果表明,TCM 对阳性和阴性症状量表(PANSS)的总分变化和阴性症状评分变化等方面有有益的影响,以及用 PANSS 或简明精神病评定量表(BPRS)估计的临床效果。在相关试验的两组中,从基线到治疗期末的锥体外系副作用(RSESE)评分的变化相似。TCM 还被报道可以减轻一些抗精神病相关的副作用,总的来说,TCM 辅助治疗通常是安全和耐受良好的。虽然结果表明 TCM 作为难治性精神分裂症治疗的替代辅助治疗具有潜在的应用价值,但仍需要进一步的高质量研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/fafde38c4c3d/41598_2018_24547_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/72adff6699f0/41598_2018_24547_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/51a1fb939a1d/41598_2018_24547_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/aa7ac9665e27/41598_2018_24547_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/d9aeede5230b/41598_2018_24547_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/40077356679f/41598_2018_24547_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/97487c411cc5/41598_2018_24547_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/fafde38c4c3d/41598_2018_24547_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/72adff6699f0/41598_2018_24547_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/51a1fb939a1d/41598_2018_24547_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/aa7ac9665e27/41598_2018_24547_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/d9aeede5230b/41598_2018_24547_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/40077356679f/41598_2018_24547_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/97487c411cc5/41598_2018_24547_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4970/5906629/fafde38c4c3d/41598_2018_24547_Fig7_HTML.jpg

相似文献

1
Effectiveness of Traditional Chinese Medicineas as an Adjunct Therapy for Refractory Schizophrenia: A Systematic Review and Meta Analysis.中药辅助治疗难治性精神分裂症的疗效:系统评价和荟萃分析。
Sci Rep. 2018 Apr 18;8(1):6230. doi: 10.1038/s41598-018-24547-0.
2
Chinese herbal medicine for schizophrenia.用于治疗精神分裂症的中草药
Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD003444. doi: 10.1002/14651858.CD003444.pub2.
3
Traditional Chinese Medicine Decoction Combined With Antipsychotic for Chronic Schizophrenia Treatment: A Systematic Review and Meta-analysis.中药汤剂联合抗精神病药物治疗慢性精神分裂症:一项系统评价与Meta分析
Front Pharmacol. 2021 Jan 20;11:616088. doi: 10.3389/fphar.2020.616088. eCollection 2020.
4
Wendan decoction (Traditional Chinese medicine) for schizophrenia.温胆汤(中药)治疗精神分裂症
Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD012217. doi: 10.1002/14651858.CD012217.pub2.
5
Efficacy and safety of a Chinese medicine formula Diankuang Mengxing Decoction combined with antipsychotics in the treatment of schizophrenia: A meta-analysis of randomized controlled trials.中药复方癫狂梦醒汤联合抗精神病药物治疗精神分裂症的疗效和安全性的 Meta 分析:随机对照试验研究。
Medicine (Baltimore). 2024 Sep 6;103(36):e39489. doi: 10.1097/MD.0000000000039489.
6
A double-blind, placebo-controlled study of traditional Chinese medicine sarsasapogenin added to risperidone in patients with negative symptoms dominated schizophrenia.一项中药薯蓣皂苷元联合利培酮治疗以阴性症状为主的精神分裂症的双盲、安慰剂对照研究。
Neurosci Bull. 2011 Aug;27(4):258-68. doi: 10.1007/s12264-011-1417-6.
7
Wendan decoction (温胆汤) for treatment of schizophrenia: a systematic review of randomized controlled trials.温胆汤治疗精神分裂症:随机对照试验的系统评价
Chin J Integr Med. 2016 Apr;22(4):302-10. doi: 10.1007/s11655-015-2047-z. Epub 2015 Apr 6.
8
Traditional Chinese Medicine as an adjunct therapy in the treatment of idiopathic membranous nephropathy: A systematic review and meta-analysis.中药辅助治疗特发性膜性肾病:系统评价和荟萃分析。
PLoS One. 2021 May 14;16(5):e0251131. doi: 10.1371/journal.pone.0251131. eCollection 2021.
9
Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis).柴胡加龙骨牡蛎汤治疗难治性精神分裂症的疗效与安全性:一项随机、双盲、安慰剂对照试验(阳性与阴性症状量表,五因素分析)
Psychopharmacology (Berl). 2015 Jan;232(1):155-64. doi: 10.1007/s00213-014-3645-8. Epub 2014 Jun 13.
10
Effectiveness of traditional Chinese medicine as an adjunct therapy for Parkinson's disease: a systematic review and meta-analysis.中药作为帕金森病辅助治疗的有效性:一项系统评价和荟萃分析。
PLoS One. 2015 Mar 10;10(3):e0118498. doi: 10.1371/journal.pone.0118498. eCollection 2015.

引用本文的文献

1
Traditional Chinese Medicine Decoction Combined With Antipsychotic for Chronic Schizophrenia Treatment: A Systematic Review and Meta-analysis.中药汤剂联合抗精神病药物治疗慢性精神分裂症:一项系统评价与Meta分析
Front Pharmacol. 2021 Jan 20;11:616088. doi: 10.3389/fphar.2020.616088. eCollection 2020.
2
Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les médicaments à base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une méta-revue des méta-analyses d'essais randomisés contrôlés.植物药(植物药)治疗精神障碍:随机对照试验荟萃分析的荟萃评价:植物药(植物药)治疗精神障碍:随机对照试验荟萃分析的荟萃评价。
Can J Psychiatry. 2021 Oct;66(10):849-862. doi: 10.1177/0706743720979917. Epub 2021 Feb 18.
3

本文引用的文献

1
A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia.一种治疗精神分裂症的新型生物-心理-社会-行为治疗模式。
Int J Mol Sci. 2017 Mar 30;18(4):734. doi: 10.3390/ijms18040734.
2
The treatment of schizophrenia: Can we raise the standard of care?精神分裂症的治疗:我们能否提高护理标准?
Aust N Z J Psychiatry. 2016 Dec;50(12):1128-1138. doi: 10.1177/0004867416672725. Epub 2016 Nov 7.
3
Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Women With Schizophrenia: A Randomized Controlled Trial.
Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia.棕榈酸帕利哌酮每月一次给药在中国近期发病精神分裂症患者中的长期疗效及安全性
Neuropsychiatr Dis Treat. 2019 Jun 27;15:1685-1694. doi: 10.2147/NDT.S191803. eCollection 2019.
芍药甘草汤治疗女性精神分裂症患者抗精神病药物相关高催乳素血症的随机对照试验
J Clin Psychopharmacol. 2016 Dec;36(6):572-579. doi: 10.1097/JCP.0000000000000607.
4
Traditional Chinese medicine for schizophrenia: A survey of randomized trials.用于精神分裂症的传统中药:随机试验综述
Asia Pac Psychiatry. 2017 Mar;9(1). doi: 10.1111/appy.12265. Epub 2016 Oct 13.
5
Incidence of Antipsychotic-Associated Side Effects: Impact of Clinician Versus Patient Ratings and Change Versus Absolute Scores.抗精神病药物相关副作用的发生率:临床医生评分与患者评分的影响以及变化分数与绝对分数的影响。
J Clin Psychopharmacol. 2016 Dec;36(6):593-596. doi: 10.1097/JCP.0000000000000569.
6
Could cannabidiol be used as an alternative to antipsychotics?大麻二酚能否用作抗精神病药物的替代品?
J Psychiatr Res. 2016 Sep;80:14-21. doi: 10.1016/j.jpsychires.2016.05.013. Epub 2016 May 28.
7
Neurosurgery for schizophrenia: an update on pathophysiology and a novel therapeutic target.精神分裂症的神经外科治疗:病理生理学的最新进展及新的治疗靶点
J Neurosurg. 2016 Apr;124(4):917-28. doi: 10.3171/2015.4.JNS15120. Epub 2015 Oct 30.
8
Study on the methodology of developing evidence-based clinical practice guidelines of Chinese medicine.中医循证临床实践指南制定方法的研究
Chin J Integr Med. 2015 Nov;21(11):874-80. doi: 10.1007/s11655-014-1896-1. Epub 2014 Dec 18.
9
Schizophrenia: overview and dopamine dysfunction.精神分裂症:概述与多巴胺功能障碍
J Clin Psychiatry. 2014 Nov;75(11):e31. doi: 10.4088/JCP.13078tx2c.
10
Clozapine for treatment-resistant bipolar disorder: a systematic review.氯氮平治疗难治性双相情感障碍:系统评价。
Bipolar Disord. 2015 May;17(3):235-47. doi: 10.1111/bdi.12272. Epub 2014 Oct 27.